Two Phase 1 dose-escalation studies exploring multiple regimens of litronesib (LY2523355), an Eg5 inhibitor, in patients with advanced cancer
| Image |  |
|---|---|
| Description | scientific article published on 17 January 2017 |
| Author/s |
author: Claire F. Verschraegen |
| Publication date | January 17, 2017 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |